BioWorld Science

April 9, 2020

View Archived Issues

Converting catch and release to PARP traps

Read More

Novavax to initiate first-in-human studies of its new coronavirus candidate

Read More

Solnatide approved for compassionate use in Austria for treatment of severe COVID-19

Read More

Biophytis launches COVA clinical program of Sarconeos in COVID-19

Read More

Active compound of WP-1122 reduces coronavirus replication in vitro

Read More

Program to prevent the severe respiratory effects of COVID-19 using LAMELLASOME technology

Read More

Ariagen patents prodrugs for cancer

Read More

Clinical trial application for ACN-00177 approved in the U.K.

Read More

Thomas Jefferson University develops COVID-19 vaccine candidate

Read More

Cardurion Pharmaceuticals presents CAMK2 inhibitors

Read More

MediciNova to initiate clinical trial of ibudilast for COVID-19 ARDS

Read More

Enanta Pharmaceuticals identifies compounds for HBV infection

Read More

Discovery of a novel antimalarial compound, CHMFL-PI4K-127

Read More

Butantan-DV demonstrates safety and immunogenicity in phase II study

Read More

Jnana Therapeutics describes new compounds targeting mutant mammalian proteins

Read More

Focusing on commonalities to fight projected most common cause of death

Read More

New t-PA, u-PA and plasmin inhibitors presented by Alxerion Biotech

Read More

OncoImmune cleared to begin phase III study of CD24Fc for hospitalized patients with COVID-19

Read More

FDA approves Braftovi for metastatic colorectal cancer with BRAF V600E mutation

Read More

Sirnaomics reports phase II interim data on STP-705 for cutaneous squamous cell carcinoma in situ

Read More

Aivita offers updated survival data from phase II trial of AV-GBM-1 in glioblastoma

Read More

L-Leucine predicts lower mortality in patients with heart failure and preserved ejection fraction

Read More

CSL Behring and SAB partner on development of COVID-19 therapeutic candidate SAB-185

Read More